Achieving timely positive coverage determinations from payors is a critical success factor that many non-drug medical technologies innovators do not adequately prepare for when entering the U.S. market. A panel of expert stakeholders from a U.S. Payor, FDAs Early Payor Feedback Program, EXCITE International and an innovative company will discuss the situation and solutions that adoption decision-makers have developed to deal with the situation.
• Laurel Soot, M.D., VP Medical Management, Providence Health Plan.
• Kelly Wilkicki, Senior Advisor for Innovation FDA/CDRH
• Leslie Levin, M.D., CEO and Chief Scientific Officer EXCITE International
• Geir Almas, Executive Chairman, SoftOx Solutions
Moderated by Raj Malik, VP of Federal Affairs and National Strategic Partnerships. Medtech Canada
RSVP here: https://forms.gle/aNAF9vrLPYtEsVFq7